BioForce Nanosciences Valuation
| BFNH Stock | USD 1.09 0.00 0.00% |
Today, the firm appears to be overvalued. BioForce Nanosciences shows a prevailing Real Value of $0.89 per share. The current price of the firm is $1.09. Our model approximates the value of BioForce Nanosciences from analyzing the firm fundamentals such as Return On Asset of -21.84, price to earning of (1.52) X, and Shares Outstanding of 29.27 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioForce Nanosciences' price fluctuation is abnormally volatile at this time. Calculation of the real value of BioForce Nanosciences is based on 3 months time horizon. Increasing BioForce Nanosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BioForce Nanosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioForce Pink Sheet. However, BioForce Nanosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.09 | Real 0.89 | Hype 1.09 | Naive 1.03 |
The intrinsic value of BioForce Nanosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence BioForce Nanosciences' stock price.
Estimating the potential upside or downside of BioForce Nanosciences Holdings helps investors to forecast how BioForce pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioForce Nanosciences more accurately as focusing exclusively on BioForce Nanosciences' fundamentals will not take into account other important factors: BioForce Nanosciences Total Value Analysis
BioForce Nanosciences Holdings is currently estimated to have valuation of 50.2 M with market capitalization of 72.74 M, debt of 156.87 K, and cash on hands of 9.23 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioForce Nanosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
50.2 M | 72.74 M | 156.87 K | 9.23 K |
BioForce Nanosciences Asset Utilization
One of the ways to look at asset utilization of BioForce is to check how much profit was generated for every dollar of assets it reports. BioForce Nanosciences Holdings shows a negative utilization of assets of -21.84 percent, losing $0.22 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of BioForce Nanosciences Holdings shows how discouraging it operates for each dollar spent on its assets.BioForce Nanosciences Ownership Allocation
BioForce Nanosciences holds a total of 29.27 Million outstanding shares. BioForce Nanosciences Holdings shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.29 percent of BioForce Nanosciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioForce Nanosciences Profitability Analysis
Net Loss for the year was (501.95 K) with profit before overhead, payroll, taxes, and interest of 4.36 K.About BioForce Nanosciences Valuation
An absolute valuation paradigm, as applied to BioForce Pink Sheet, attempts to find the value of BioForce Nanosciences based on its fundamental and basic technical indicators. By analyzing BioForce Nanosciences's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BioForce Nanosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioForce Nanosciences. We calculate exposure to BioForce Nanosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioForce Nanosciences's related companies.BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
8 Steps to conduct BioForce Nanosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioForce Nanosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioForce Nanosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioForce Nanosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioForce Nanosciences' revenue streams: Identify BioForce Nanosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioForce Nanosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioForce Nanosciences' growth potential: Evaluate BioForce Nanosciences' management, business model, and growth potential.
- Determine BioForce Nanosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioForce Nanosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioForce Nanosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 16.3 M | |
| Retained Earnings | -159.7 M | |
| Retained Earnings Total Equity | -159.7 M |
Complementary Tools for BioForce Pink Sheet analysis
When running BioForce Nanosciences' price analysis, check to measure BioForce Nanosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioForce Nanosciences is operating at the current time. Most of BioForce Nanosciences' value examination focuses on studying past and present price action to predict the probability of BioForce Nanosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioForce Nanosciences' price. Additionally, you may evaluate how the addition of BioForce Nanosciences to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |